Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients

Background Magnetic Resonance Imaging (MRI) techniques provided evidences into the understanding of cognitive impairment (CIm) in Multiple Sclerosis (MS). Objectives To investigate the role of white matter (WM) and gray matter (GM) in predicting long-term CIm in a cohort of MS patients. Methods 303 out of 597 patients participating in a previous multicenter clinical-MRI study were enrolled (49.4% were lost at follow-up). The following MRI parameters, expressed as fraction (f) of intracranial volume, were evaluated: cerebrospinal fluid (CSF-f), WM-f, GM-f and abnormal WM (AWM-f), a measure of lesion load. Nine years later, cognitive status was assessed in 241 patients using the Symbol Digit Modalities Test (SDMT), the Semantically Related Word List Test (SRWL), the Modified Card Sorting Test (MCST), and the Paced Auditory Serial Addition Test (PASAT). In particular, being SRWL a memory test, both immediate recall and delayed recall were evaluated. MCST scoring was calculated based on the number of categories, number of perseverative and non-perseverative errors. Results AWM-f was predictive of an impaired performance 9 years ahead in SDMT (OR 1.49, CI 1.12–1.97 p = 0.006), PASAT (OR 1.43, CI 1.14–1.80 p = 0.002), SRWL-immediate recall (OR 1.72 CI 1.35–2.20 p<0.001), SRWL-delayed recall (OR 1.61 CI 1.28–2.03 p<0.001), MCST-category (OR 1.52, CI 1.2–1.9 p<0.001), MCST-perseverative error(OR 1.51 CI 1.2–1.9 p = 0.001), MCST-non perseverative error (OR 1.26 CI 1.02–1.55 p = 0.032). Conclusion In our large MS cohort, focal WM damage appeared to be the most relevant predictor of the long-term cognitive outcome.

[1]  P. Feys,et al.  Measuring the cost of cognitive-motor dual tasking during walking in multiple sclerosis , 2015, Multiple sclerosis.

[2]  A. Thompson,et al.  Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. , 1999, Brain : a journal of neurology.

[3]  R. Benedict,et al.  Validity of the Wisconsin Card Sorting and Delis–Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis , 2007, Journal of clinical and experimental neuropsychology.

[4]  M. Deloire,et al.  Cognitive impairment differs between primary progressive and relapsing-remitting MS , 2013, Neurology.

[5]  R I Grossman,et al.  MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.

[6]  M. Rovaris,et al.  MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction , 2006, Journal of Neurological Sciences.

[7]  G Luccichenti,et al.  Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study , 2009, Multiple sclerosis.

[8]  G. Tedeschi,et al.  Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study , 2014, Multiple sclerosis.

[9]  A. Smith.  Symbol Digit Modalities Test , 2016 .

[10]  A. Kunkel,et al.  How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis? , 2014, Journal of the Neurological Sciences.

[11]  S. Sorbi,et al.  The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population , 2006, Multiple sclerosis.

[12]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[13]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[14]  Hirofumi Ochi,et al.  [Cognitive impairment in multiple sclerosis]. , 2014, Brain and nerve = Shinkei kenkyu no shinpo.

[15]  Bruno Alfano,et al.  Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis , 2000 .

[16]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[17]  G. Siracusa,et al.  Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis , 2008, Neurology.

[18]  J. Leathem,et al.  The Effects of Test Anxiety, Age, Intelligence Level, and Arithmetic Ability on Paced Auditory Serial Addition Test Performance , 2004, Applied neuropsychology.

[19]  P. Pasqualetti,et al.  La valutazione delle funzioni esecutive nella pratica neuropsicologica: dal Modified Card Sorting Test al Modified Card Sorting Test: Roma Version. Dati di standardizzazione , 2002 .

[20]  M. Horsfield,et al.  Gray matter damage predicts the accumulation of disability 13 years later in MS , 2013, Neurology.

[21]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[22]  V. Dousset,et al.  MRI predictors of cognitive outcome in early multiple sclerosis , 2011, Neurology.

[23]  Lippincott Williams Wilkins,et al.  MRI predictors of cognitive outcome in early multiple sclerosis , 2012, Neurology.

[24]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[25]  H. Nelson.  A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.

[26]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[27]  A. Gass,et al.  Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis , 2013, Multiple sclerosis.

[28]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[29]  Ludwig Kappos,et al.  Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing‐remitting multiple sclerosis , 2010, Human brain mapping.

[30]  I. Evangelou,et al.  Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[31]  M. Trojano,et al.  Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study , 2011, BMC neurology.

[32]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.

[33]  M. Sá,et al.  Cognitive Dysfunction in Multiple Sclerosis , 2012, Front. Neur..

[34]  G Cazzato,et al.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[35]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[36]  Alan J. Thompson,et al.  Linking white matter tracts to associated cortical grey matter: A tract extension methodology , 2012, NeuroImage.

[37]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[38]  Dieter Vaitl,et al.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS , 2006, NeuroImage.

[39]  M. Ron,et al.  Cognitive impairment in relapsing—remitting multiple sclerosis can be predicted by imaging performed several years earlier , 2008, Multiple sclerosis.